MERIT’s respiratory case studies demonstrate that our quality overreads, fast turnaround times, and easy-to-reach RTs will help you move your trial forward....
Author: clients_p17yrv
You need a partner that not only delivers access to a deep bench of SMEs and a secure imaging platform, but also has the clinical operations experience to drive study milestone achievement....
Article, Ophthalmology / 28.02.2023
First Anti-VEGF Treatment Approved for Retinopathy of Prematurity
ROP is one of the leading causes of childhood blindness globally. The availability of an FDA approved medication for ROP represents an important alternative for preterm infants and their parents...
Article, Oncology / 13.02.2023
PCWG3 and Oncology Endpoints Webinar Summary PCWG3 and PSMA PET/CT Response Criteria
Learn more about the fundamentals of PCWG3 response criteria, PSMA PET/CT response criteria, data collection, and response assessment....
Article / 03.02.2023
PCWG3 and Oncology Imaging Endpoints Webinar Summary Imaging Modalities in Prostate Cancer
Learn more about bone scans and PSMA PET/CT scans in prostate cancer, including procedure overviews and tips for success. ...
Article / 24.01.2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Antibody-Drug Conjugates (ADCs) Five Treatments to Watch in Early Phase Prostate Cancer Clinical Trials
Learn more about ADCs, a new and potentially favorable approach for treating prostate cancer....
Article, Clinical Trial Research / 21.12.2022
Supporting Decentralized Clinical Trials (DCTs) with Secure Cloud-Based Data Platforms
Learn about the most common types of Decentralized Clinical Trials (DCTs) and how to make their vast data sets actionable with secure, cloud-based data platforms....
Article, Oncology / 15.12.2022
Fundamentals of iRECIST and Oncology Trial Endpoints MERIT Webinar Key Takeaways
Learn about the rules and principles of iRECIST, imaging endpoints, and special considerations for using iRECIST response criteria....
MERIT's VP of Oncology, Shinji Yue, explains why he chose to work in the clinical trials industry and outlines what he thinks is MERIT's biggest differentiator....
MERIT attended the WG-09: Ophthalmology meeting at AAO 2022. Read our article for several key takeaways. ...
Article / 17.10.2022Take Control of Your Clinical Trial:
Take Control of Your Clinical Trial:
How an Imaging Core Lab Can Help Overcome Common Study Challenges MERIT Webinar Key Takeaways
MERIT’s webinar provides key takeaways that are important for oncology imaging clinical trials along with insights on how an Imaging Core Lab (ICL) can help you address imaging trial challenges. ...
Learn about the principles and recommendations of RANO response criteria for high grade glioma (HGG) and the imaging endpoint information that needs to be collected for clinical trials....